ILiAD Biotechnologies
Board
3 directors, no change since October 2026Director
appointed by deed of 17-01-2020
term without a fixed end
listed in the 2025 annual accounts, filed on 30-09-2026
Director, permanent representative
appointed by deed of 17-01-2020
term without a fixed end
listed in the 2025 annual accounts, filed on 30-09-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- “Tweede besluit: benoeming bestuurder De benoeming als bestuurder, met ingang van 21 maart 2025 de heer , wonende te Hillbourne Ter, North…”deed of 30-06-2025
Permanent representatives 1
Mandates through the years
6 names, the dashed line is todayDirector
Director
Director
Director
Director
Director
BoardEarlierend not dated
Mandates as a list
-
- Director, appointed by deed of 17-01-2020, still in office
-
- Director, appointed by deed of 17-01-2020, still in office
- Day-to-day manager, appointed by deed of 07-07-2020, last mentioned in 2020
-
- Director, appointed by deed of 20-10-2026, still in office
-
- Director, from 21-03-2025 to 10-07-2025
-
- Director, appointed by deed of 30-06-2025, no longer listed in the 2025 annual accounts
-
- Director, appointed by deed of 17-01-2020, until 14-12-2024
Control
Founder
This company
ILiAD Biotechnologies
Equity €25,626
Loss €76,960 in 2025
Capital
- Contribution
- €592,745.50
- Shares
- 1,000,000
- Contribution per share
- €0.59
- Equity per share
- €0.03 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 17-01-2020 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 3 directors
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Alle machten genoemd in artikel 2:87 Wetboek van vennootschappen en verenigingen,zonder bijzondere machtiging, één of meer vereffenaars door…”
Shareholders
At incorporation
deed of 17-01-2020 ↗
- 1,000,000 shares (100%) · in cash